Cargando…
Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491010/ https://www.ncbi.nlm.nih.gov/pubmed/32495654 http://dx.doi.org/10.2217/epi-2020-0154 |
| _version_ | 1783582132641202176 |
|---|---|
| author | Ayaz, Sameer Crea, Francesco |
| author_facet | Ayaz, Sameer Crea, Francesco |
| author_sort | Ayaz, Sameer |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7491010 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Future Medicine Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74910102020-09-24 Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents Ayaz, Sameer Crea, Francesco Epigenomics Editorial Future Medicine Ltd 2020-06-04 2020-04 /pmc/articles/PMC7491010/ /pubmed/32495654 http://dx.doi.org/10.2217/epi-2020-0154 Text en © 2020 Future Medicine Ltd This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/) |
| spellingShingle | Editorial Ayaz, Sameer Crea, Francesco Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents |
| title | Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents |
| title_full | Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents |
| title_fullStr | Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents |
| title_full_unstemmed | Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents |
| title_short | Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents |
| title_sort | targeting sars-cov-2 using polycomb inhibitors as antiviral agents |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491010/ https://www.ncbi.nlm.nih.gov/pubmed/32495654 http://dx.doi.org/10.2217/epi-2020-0154 |
| work_keys_str_mv | AT ayazsameer targetingsarscov2usingpolycombinhibitorsasantiviralagents AT creafrancesco targetingsarscov2usingpolycombinhibitorsasantiviralagents |